查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1888544

新生兒篩檢市場規模、佔有率和趨勢分析報告：按產品、技術、檢測類型、地區和細分市場預測（2025-2033 年）

Newborn Screening Market Size, Share & Trends Analysis Report By Product, By Technology, By Test Type, By Region, and Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

新生兒篩檢市場摘要

全球新生兒篩檢市場預計在 2024 年達到 9.0063 億美元，預計到 2033 年將達到 17.9738 億美元，2025 年至 2033 年的複合年成長率為 8.1%。

預計在預測期內，新生兒數量增加、新生兒先天性疾病病例增多、消費者意識提高以及各國政府的有利舉措和支持將推動多個計畫和立法舉措，這些因素將推動市場發展。

根據聯合國經濟和社會事務部（UN DESA）發布的《2024年世界人口展望》，全球出生率預計將保持高位，2024年預計將有1.324億嬰兒出生。此外，世界衛生組織（WHO）估計，先天性疾病（子宮內發育過程中出現的結構或功能異常）將影響全球整體約6%的新生兒。一項更詳細的評估——一項針對先天性疾病的全球、區域和國家篩檢調查方法將有助於市場擴張。例如，美國的Levity公司於2023年11月發布了EONIS Q系統，該系統是一個獲得CE-IVD認證的平台。這將使核准CE 標誌的國家的實驗室能夠引入新生兒脊髓性肌肉萎縮症 (SMA) 和嚴重聯合免疫力缺乏(SCID) 的分子檢測。

此外，新生兒先天性疾病盛行率的顯著上升預計將對新生兒篩檢市場的成長產生積極影響。根據世界衛生組織（世衛組織）2023年2月發布的數據，全球每年約有24萬名新生兒在出生後28天內死於先天性疾病。此外，據估計，1個月至5歲兒童中約有17萬例死亡是由先天性疾病造成的。另外，根據印度小兒科會的資料，印度每1,000名新生兒中就有2.1例患有先天性甲狀腺機能低下症，先天性代謝性疾病的盛行率在2%至7.8%之間。預計新生兒先天性疾病的高發生率將促使檢測普及率的提高，進而在2030年前加速市場成長。

此外，政府計畫和相關法規的推出預計將為新生兒篩檢的發展創造有利環境。世界各地的計畫正引領新生兒篩檢邁入基因組時代。例如，預計到2023年，將有10萬名嬰兒參與一項採用次世代定序（NGS）技術的新生兒篩檢試驗計畫。 Illumina公司參與了至少九項國內外的大規模基因組新生兒篩檢研究，篩檢像多達4萬名嬰兒。這些研究包括美國的GUARDIAN計畫、英國的Generation Study計畫、澳洲的BabyScreen+計畫以及比利時的BabyDetect計畫。

預計隨著新技術和治療方案的引入，新生兒檢測的需求將受到影響，這些新技術和治療方案將能夠診斷約29種新生兒疾病，包括半乳糖血症（GS）、苯酮尿症（PKU）、聽力障礙和先天性甲狀腺機能低下症（CH）。 2023年3月，美國疾病管制與預防美國（CDC）實驗室科學部門的一組研究人員宣布推出改良型檢測方法，這些方法採用先進技術診斷遺傳性疾病。

目錄

第1章新生兒篩檢市場：調查方法與範圍

第2章新生兒篩檢市場：執行摘要

  • 市場概覽
  • 產品概述
  • 技術概述
  • 測試類型概述
  • 競爭格局概述

第3章新生兒篩檢市場變數、趨勢和範圍

  • 市場區隔和範圍
  • 市場體系展望
    • 母市場展望
    • 相關及附隨市場展望
  • 市場動態
  • 市場促進因素分析
    • 新生兒數量不斷增加
    • 新生兒先天性疾病病例不斷增加
    • 消費者意識的提高與有利的政策
    • 支持各級政府的多項計畫和立法舉措
  • 市場限制因素分析
    • 高成本且取得途徑有限
    • 基礎設施和熟練勞動力短缺
    • 篩檢方法的差異
  • 波特五力分析
  • PESTLE分析
  • 管道分析

第4章新生兒篩檢市場：產品估算與趨勢分析

  • 新生兒篩檢市場：產品差異分析
  • 裝置
    • 設備市場，2021-2033年
  • 試劑
    • 試劑市場，2021-2033年

第5章新生兒篩檢市場：技術預測與趨勢分析

  • 新生兒篩檢市場：技術波動分析
  • 串聯式質譜質譜法
    • 串聯式質譜質譜市場，2021-2033年
  • 脈搏血氧計
    • 脈搏血氧計市場，2021-2033年
  • 基於酵素的檢測
    • 2021-2033年酵素分析方法市場
  • DNA檢測
    • DNA檢測市場，2021-2033年
  • 電泳
    • 電泳市場，2021-2033年

第6章新生兒篩檢市場：檢測類型估算與趨勢分析

  • 新生兒篩檢市場：檢測類型差異分析
  • 乾血斑測試
    • 2021-2033年乾血斑檢測市場
  • CCHD
    • 先天性心臟病檢測市場，2021-2033年
  • 聽力篩檢
    • 2021-2033年聽力篩檢市場

第7章新生兒篩檢市場：按地區分類的業務分析

  • 區域市場概覽
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第8章 競爭情勢

  • 公司分類
  • 策略規劃
    • 新產品發布
    • 合夥
    • 獲得
    • 合資
    • 資金籌措
  • 主要企業市佔率分析（2024 年）
  • 公司熱力圖分析
  • 公司簡介
    • Bio-Rad Laboratories
    • Agilent Technologies
    • Masimo
    • Waters Corporation
    • Natus Medical
    • Trivitron Healthcare
    • GE Lifesciences
    • PerkinElmer Inc
    • AB SCIEX
    • Demand A/S
    • Parseq LAB
    • Otodynamics
    • Zentech
    • Centogene
Product Code: 978-1-68038-490-1

Newborn Screening Market Summary

The global newborn screening market size was estimated at USD 900.63 million in 2024 and is projected to reach USD 1,797.38 million by 2033, growing at a CAGR of 8.1% from 2025 to 2033. The rising neonatal population, increasing cases of congenital diseases in newborns, growing consumer awareness, and favorable initiatives & support from various governments, which are organizing several programs & legislations, are factors estimated to propel the market over the forecast period.

According to the United Nations Department of Economic and Social Affairs (UN DESA) World Population Prospects 2024, the global number of births remains high, with an estimated 132.4 million babies born worldwide in 2024. Moreover, according to the World Health Organization (WHO), congenital disorders - structural or functional anomalies that occur during intra-uterine life - affect an estimated 6% of all births worldwide. In a more detailed assessment, a global, regional, and national epidemiology study of congenital disabilities found that in 2021, about 31.64 million children (aged 0-14 years) were living with congenital disabilities, representing a 6.68% increase since 1990. In addition, technological advancements in screening methodologies are also expected to boost the market. For instance, in November 2023, Revvity, Inc. (US) launched its EONIS Q system, a CE-IVD declared platform enabling laboratories in countries that accept the CE marking to adopt molecular testing for spinal muscular atrophy (SMA) and severe combined immunodeficiency (SCID) in newborns.

Furthermore, extensively increasing prevalence of congenital diseases in newborns is expected to have a positive impact on the newborn screening market growth. According to data published by WHO in February 2023, an estimated 240,000 newborns within 28 days of birth die each year globally due to congenital diseases. Congenital disorders are further responsible for an estimated 170, 000 child deaths in the age group of 1 month to 5 years. In addition, according to information from Indian Pediatrics, congenital hypothyroidism occurs in 2.1 out of every 1,000 infants in India, and the prevalence of inborn metabolic abnormalities ranges from 2 to 7.8%. Such a substantial occurrence of congenital diseases amongst newborns is likely to increase the adoption of tests, which is expected to accelerate the market growth by 2030.

In addition, the introduction of government programs and legislation is also expected to offer a favorable environment for newborn screening market growth. Programs around the globe bring newborn screening into the Genome Era. For instance, in 2023, an anticipated 100,000 infants participated in an NGS newborn screening pilot program. Illumina has participated in at least nine large-scale national and international genomic NBS investigations, screening up to 40,000 babies. This includes GUARDIAN in the U.S., Generation Study in the United Kingdom, BabyScreen+ in Australia, and BabyDetect in Belgium.

The demand for newborn procedures is expected to be influenced by the introduction of new technologies and the availability of treatment options enabling the diagnosis of about 29 possible disorders, such as galactosemia (GS), phenylketonuria (PKU), hearing disorders, and congenital hypothyroidism (CH) in neonates. In March 2023, a group of scientists at the Division of Laboratory Sciences, CDC, announced the introduction of improved tests that offer advanced technology for the diagnosis of genetic diseases.

Global Newborn Screening Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the newborn screening market based on product, technology, test type, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments
  • Reagents
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Tandem mass spectrometry
  • Pulse oximetry
  • Enzyme based assay
  • DNA assay
  • Electrophoresis
  • Others
  • Test Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Dry blood spot test
  • CCHD
  • Hearing screen
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Newborn Screening Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product Method
      • 1.1.1.2. Technology Segment
      • 1.1.1.3. Test Type Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Newborn Screening Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Product Snapshot
  • 2.3. Technology Snapshot
  • 2.4. Test Type Snapshot
  • 2.5. Competitive Landscape Snapshot

Chapter 3. Newborn Screening Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Rising neonatal population
    • 3.4.2. Increasing cases of congenital diseases in newborns
    • 3.4.3. Growing consumer awareness, and favorable initiatives
    • 3.4.4. Support from various governments organizing several programs & legislations
  • 3.5. Market Restraint Analysis
    • 3.5.1. High costs and limited accessibility
    • 3.5.2. Infrastructure and skilled workforce deficiencies
    • 3.5.3. Variations in screening practices
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. Newborn Screening Market: Product Estimates & Trend Analysis

  • 4.1. Newborn Screening Market: Product Movement Analysis
  • 4.2. Instruments
    • 4.2.1. Instruments market, 2021 - 2033 (USD Million)
  • 4.3. Reagents
    • 4.3.1. Reagents market, 2021 - 2033 (USD Million)

Chapter 5. Newborn Screening Market: Technology Estimates & Trend Analysis

  • 5.1. Newborn Screening Market: Technology Movement Analysis
  • 5.2. Tandem mass spectrometry
    • 5.2.1. Tandem mass spectrometry market, 2021 - 2033 (USD Million)
  • 5.3. Pulse oximetry
    • 5.3.1. Pulse oximetry market, 2021 - 2033 (USD Million)
  • 5.4. Enzyme based assay
    • 5.4.1. Enzyme based assays market, 2021 - 2033 (USD Million)
  • 5.5. DNA assays
    • 5.5.1. DNA assays market, 2021 - 2033 (USD Million)
  • 5.6. Electrophoresis
    • 5.6.1. Electrophoresis market, 2021 - 2033 (USD Million)

Chapter 6. Newborn Screening Market: Test Type Estimates & Trend Analysis

  • 6.1. Newborn Screening Market: Test Type Movement Analysis
  • 6.2. Dry blood spot test
    • 6.2.1. Dry blood spot test market, 2021 - 2033 (USD Million)
  • 6.3. CCHD
    • 6.3.1. CCHD test market, 2021 - 2033 (USD Million)
  • 6.4. Hearing screen
    • 6.4.1. Hearing screen test market, 2021 - 2033 (USD Million)

Chapter 7. Newborn Screening Market: Regional Business Analysis

  • 7.1. Regional Market Snapshot
  • 7.2. North America
    • 7.2.1. North America Newborn Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.2.2.2. Key Country Dynamics
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. Reimbursement Scenario
      • 7.2.2.5. Competitive Scenario
    • 7.2.3. Canada
      • 7.2.3.1. Canada Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.2.3.2. Key Country Dynamics
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Reimbursement Scenario
      • 7.2.3.5. Competitive Scenario
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.2.4.2. Key Country Dynamics
      • 7.2.4.3. Regulatory Framework
      • 7.2.4.4. Reimbursement Scenario
      • 7.2.4.5. Competitive Scenario
  • 7.3. Europe
    • 7.3.1. Europe Newborn Screening Market, 2021 - 2033 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.3.2.2. Key Country Dynamics
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. Reimbursement Scenario
      • 7.3.2.5. Competitive Scenario
    • 7.3.3. Germany
      • 7.3.3.1. Germany Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.3.3.2. Key Country Dynamics
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Reimbursement Scenario
      • 7.3.3.5. Competitive Scenario
    • 7.3.4. Spain
      • 7.3.4.1. Spain Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.3.4.2. Key Country Dynamics
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Reimbursement Scenario
      • 7.3.4.5. Competitive Scenario
    • 7.3.5. France
      • 7.3.5.1. France Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.3.5.2. Key Country Dynamics
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Reimbursement Scenario
      • 7.3.5.5. Competitive Scenario
    • 7.3.6. Italy
      • 7.3.6.1. Italy Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.3.6.2. Key Country Dynamics
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Reimbursement Scenario
      • 7.3.6.5. Competitive Scenario
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.3.7.2. Key Country Dynamics
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Reimbursement Scenario
      • 7.3.7.5. Competitive Scenario
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.3.8.2. Key Country Dynamics
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Reimbursement Scenario
      • 7.3.8.5. Competitive Scenario
    • 7.3.9. Norway
      • 7.3.9.1. Norway Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.3.9.2. Key Country Dynamics
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Reimbursement Scenario
      • 7.3.9.5. Competitive Scenario
  • 7.4. Asia Pacific
    • 7.4.1. Asia-Pacific Newborn Screening Market, 2021 - 2033 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Japan Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.4.2.2. Key Country Dynamics
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Scenario
      • 7.4.2.5. Competitive Scenario
    • 7.4.3. China
      • 7.4.3.1. China Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.4.3.2. Key Country Dynamics
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Scenario
      • 7.4.3.5. Competitive Scenario
    • 7.4.4. India
      • 7.4.4.1. India Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.4.4.2. Key Country Dynamics
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Scenario
      • 7.4.4.5. Competitive Scenario
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.4.5.2. Key Country Dynamics
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Reimbursement Scenario
      • 7.4.5.5. Competitive Scenario
    • 7.4.6. Thailand
      • 7.4.6.1. Thailand Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.4.6.2. Key Country Dynamics
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Reimbursement Scenario
      • 7.4.6.5. Competitive Scenario
    • 7.4.7. Australia
      • 7.4.7.1. Australia Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.4.7.2. Key Country Dynamics
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Reimbursement Scenario
      • 7.4.7.5. Competitive Scenario
  • 7.5. Latin America
    • 7.5.1. Latin America Newborn Screening Market, 2021 - 2033 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.5.2.2. Key Country Dynamics
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Scenario
      • 7.5.2.5. Competitive Scenario
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.5.3.2. Key Country Dynamics
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Scenario
      • 7.5.3.5. Competitive Scenario
  • 7.6. MEA
    • 7.6.1. MEA Newborn Screening Market, 2021 - 2033 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.6.2.2. Key Country Dynamics
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Scenario
      • 7.6.2.5. Competitive Scenario
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.6.3.2. Key Country Dynamics
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Scenario
      • 7.6.3.5. Competitive Scenario
    • 7.6.4. UAE
      • 7.6.4.1. UAE Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.6.4.2. Key Country Dynamics
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Scenario
      • 7.6.4.5. Competitive Scenario
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Newborn Screening Market, 2021 - 2033 (USD Million)
      • 7.6.5.2. Key Country Dynamics
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Scenario
      • 7.6.5.5. Competitive Scenario

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
    • 8.2.1. New Product Launch
    • 8.2.2. Partnerships
    • 8.2.3. Acquisition
    • 8.2.4. Collaboration
    • 8.2.5. Funding
  • 8.3. Key Company Market Share Analysis, 2024
  • 8.4. Company Heat Map Analysis
  • 8.5. Company Profiles
    • 8.5.1. Bio-Rad Laboratories
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Agilent Technologies
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Masimo
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Waters Corporation
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Natus Medical
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Trivitron Healthcare
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. GE Lifesciences
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. PerkinElmer Inc
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. AB SCIEX
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Demand A/S
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
    • 8.5.11. Parseq LAB
      • 8.5.11.1. Overview
      • 8.5.11.2. Financial Performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic Initiatives
    • 8.5.12. Otodynamics
      • 8.5.12.1. Overview
      • 8.5.12.2. Financial Performance
      • 8.5.12.3. Product Benchmarking
      • 8.5.12.4. Strategic Initiatives
    • 8.5.13. Zentech
      • 8.5.13.1. Overview
      • 8.5.13.2. Financial Performance
      • 8.5.13.3. Product Benchmarking
      • 8.5.13.4. Strategic Initiatives
    • 8.5.14. Centogene
      • 8.5.14.1. Overview
      • 8.5.14.2. Financial Performance
      • 8.5.14.3. Product Benchmarking
      • 8.5.14.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Newborn Screening Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 5 Global Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 6 Global Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 7 North America Newborn Screening Market, By Country, 2021 - 2033 (USD Million)
  • Table 8 North America Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 9 North America Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 10 North America Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 11 U.S. Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 12 U.S. Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 13 U.S. Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 14 Canada Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 15 Canada Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 16 Canada Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 17 Europe Newborn Screening Market, By Country, 2021 - 2033 (USD Million)
  • Table 18 Europe Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 19 Europe Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 20 Europe Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 21 UK Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 22 UK Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 23 UK Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 24 Germany Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 25 Germany Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 26 Germany Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 27 France Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 28 France Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 29 France Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 30 Italy Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 31 Italy Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 32 Italy Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 33 Spain Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 34 Spain Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 35 Spain Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 36 Denmark Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 37 Denmark Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 38 Denmark Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 39 Sweden Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 40 Sweden Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 41 Sweden Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 42 Norway Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 43 Norway Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 44 Norway Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific Newborn Screening Market, By Country, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 49 Japan Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 50 Japan Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 51 Japan Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 52 China Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 53 China Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 54 China Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 55 India Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 56 India Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 57 India Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 58 Australia Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 59 Australia Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 60 Australia Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 61 South Korea Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 62 South Korea Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 63 South Korea Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 64 Thailand Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 65 Thailand Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 66 Thailand Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 67 Latin America Newborn Screening Market, By Country, 2021 - 2033 (USD Million)
  • Table 68 Latin America Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 69 Latin America Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 70 Latin America Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 71 Brazil Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 72 Brazil Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 73 Brazil Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 74 Mexico Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 75 Mexico Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 76 Mexico Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 77 Argentina Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 78 Argentina Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 79 MEA Newborn Screening Market, By Country, 2021 - 2033 (USD Million)
  • Table 80 MEA Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 81 MEA Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 82 MEA Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 83 South Africa Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 84 South Africa Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 85 South Africa Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 89 UAE Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 90 UAE Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 91 UAE Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 92 Kuwait Newborn Screening Market, By Product, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Newborn Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Newborn Screening Market, By Test Type, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Newborn Screening Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment.
  • Fig. 8 Market formulation & validation
  • Fig. 9 Newborn Screening Market snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook.
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Newborn Screening Market driver impact
  • Fig. 14 Newborn Screening Market restraint impact
  • Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 16 Industry Analysis - Porter's
  • Fig. 17 Strategy mapping
  • Fig. 18 Newborn Screening Market: Product outlook and key takeaways
  • Fig. 19 Newborn Screening Market: Product movement analysis & market share 2024 & 2030
  • Fig. 20 Products Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Instruments Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Reagents & Assay Kits Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Newborn Screening Market: Technology outlook and key takeaways
  • Fig. 24 Newborn Screening Market: Technology movement analysis & market share 2024 & 2030
  • Fig. 25 Tandem Mass Spectrometry Newborn Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Pulse Oximetry Newborn Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 27 Enzyme Based Assays Newborn Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 28 DNA Assays Newborn Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 29 Electrophoresis Newborn Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Newborn Screening Market: Technology outlook and key takeaways
  • Fig. 31 Newborn Screening Market: Technology movement analysis & market share 2024 & 2030
  • Fig. 32 Dry Blood Spot Test Newborn Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 33 Critical Congenital Heart Disease (CCHD) Newborn Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 34 Hearing Screen Newborn Screening Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 35 Regional marketplace: Key takeaways
  • Fig. 36 Global Newborn Screening Market: Regional movement analysis
  • Fig. 37 U.S. Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 38 Canada Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 39 Mexico Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 40 Europe Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 41 UK Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 42 Germany Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 43 France Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 44 Italy Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 45 Spain Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 46 Denmark Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 47 Sweden Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 48 Norway Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 49 Asia-Pacific Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 50 Japan Market Estimates and Forecast, 2021 - 2033(USD Million)
  • Fig. 51 China Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 52 India Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 53 South Korea Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 54 Australia Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 55 Thailand Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 56 Latin America Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 57 Brazil Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 58 Argentina Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 59 MEA Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 60 South Africa Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 61 Saudi Arabia Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 62 UAE Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 63 Kuwait Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 64 Strategy framework